Panobinostat and donor lymphocyte infusions in patients with high-risk AML and MDS
Oral azacitidine maintenance therapy for post-transplant AML
The utility of measurable residual disease (MRD) assessment in acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Venetoclax in combination with antibodies in the treatment of CLL
The role of epigenetic modulators in the pathogenesis of lymphomas
Anas Younes et al.